HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Hunaid A. Vohra John G. Wright David J. Barron William J. Brawn Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vohra, H. A. Articles by Brawn, W. J. Search for Related Content PubMed PubMed Citation Articles by Vohra, H. A. Articles by Brawn, W. J. Related Collections Congenital - acyanotic Valve disease

Eur J Cardiothorac Surg 2006;29:688-692
© 2006 Elsevier Science NL

Predicting the performance of mitral prostheses implanted in children under 5 years of age

^a Department of Cardiac Surgery, Diana, Princess of Wales Children's Hospital, Birmingham Children's Hospital NHS Trust, Steelhouse Lane Birmingham B4 6NH, United Kingdom
^b Department of Cardiology, Diana, Princess of Wales Children's Hospital, Birmingham Children's Hospital NHS Trust, Steelhouse Lane Birmingham, United Kingdom

Received 27 September 2005; received in revised form 14 January 2006; accepted 26 January 2006.

^_* Corresponding author. Tel.: +44 121 3339999; fax: +44 121 3339441. (Email: william.brawn{at}bch.nhs.uk).

Background: Mitral valve replacement (MVR) is occasionally indicated in infants and young children, necessitating the use of small prostheses. The performance of these small valves during somatic growth of the patient can lead to patient-prosthesis mismatch. This study examines performance of these valves over time to establish predicted performance and timing of replacement. Methods: Records were reviewed of all patients under 5 years of who underwent small mechanical MVR between 1988 and 2004 (n = 24). Valve sizes were between 17 and 23 mm (Bileaflet 91.6%, Tilting Disc 8.3%) with a median size of 19 mm. Mean age of patients was 1.4 ± 1.3 years with a mean weight of 7.8 ± 3.4 kg. Results: Early deaths (n = 5, 20.8%) were excluded. There were two late deaths and five patients required redo-MVR: four for outgrowth and one for acute thrombosis at 3 months. Age at redo for outgrowth was 8.6 ± 6.6 years with mean body weight of 22.5 ± 17.5 kg. Mean time between original operation and redo was 8.6 ± 6.1 years in these four patients. Follow-up was a median of 7.5 years (range 0.1–15.7 years). Overall freedom from death or valve replacement was 82.6 ± 9.1% at 5 years and 75.7 ± 10.6% at 10 years. The performance of the original prostheses showed a peak blood flow velocity across the valves of 1.5 ± 0.6 m/s at 5 years and 2.2 ± 0.5 m/s at 10 years. Seventy-five percent of the survivors still have their original valve at a mean of 8.1 ± 4.4 years postoperative with New York Heart Asociation status of I or II. Actuarial curves suggest that gradients across the valves reach a peak of >10 mmHg at a mean between 6.5 and 7 years postoperative. Conclusion: MVR in children under 5 years carries a high mortality. Nevertheless, small mechanical MVR perform remarkably well in young children with durable haemodynamics despite growth of the patients well beyond more than double the initial bodyweight. Valves can be expected to last over 8 years before requiring re-replacement.

Key Words: Mitral valve • Replacement • Children

This article has been cited by other articles:

				K. Ackermann, G. Balling, A. Eicken, T. Gunther, C. Schreiber, and J. Hess Replacement of the systemic atrioventricular valve with a mechanical prosthesis in children aged less than 6 years: Late clinical results of survival and subsequent replacement J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 750 - 756. [Abstract] [Full Text] [PDF]